Prostatype Genomics AB (publ) PGO.F Stock
Prostatype Genomics AB (publ) Price Chart
Prostatype Genomics AB (publ) PGO.F Financial and Trading Overview
| Prostatype Genomics AB (publ) stock price | 0.0042 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.04 EUR |
| Bid | 0.04 EUR x N/A |
| Ask | 0.05 EUR x N/A |
| Day's Range | 0.04 - 0.04 EUR |
| 52 Week Range | 0.02 - 0.33 EUR |
| Volume | 43K EUR |
| Avg. Volume | 769 EUR |
| Market Cap | 6.29M EUR |
| Beta (5Y Monthly) | 0.933987 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PGO.F Valuation Measures
| Enterprise Value | 941.81K EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.0206993 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Prostatype Genomics AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.933987 |
| 52-Week Change | -87.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.33 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.04 EUR |
| 200-Day Moving Average | 0.13 EUR |
PGO.F Share Statistics
| Avg. Volume (3 month) | 769 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 119.46M |
| Float | 22.61M |
| Short Ratio | N/A |
| % Held by Insiders | 15.00% |
| % Held by Institutions | 13.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.82% |
| Return on Equity (ttm) | -128.73% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 50.20% |
| Gross Profit (ttm) | -12806086 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 4.18 EUR |
| Current Ratio (mrq) | 1.093 |
| Book Value Per Share (mrq) | 2.145 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Prostatype Genomics AB (publ)
| Country | Germany |
| State | N/A |
| City | Solna |
| Address | Gustaf III:s Boulevard 34 |
| ZIP | 169 73 |
| Phone | 46 08 20 87 00 |
| Website | https://www.prostatypegenomics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
Q&A For Prostatype Genomics AB (publ) Stock
What is a current PGO.F stock price?
Prostatype Genomics AB (publ) PGO.F stock price today per share is 0.0042 EUR.
How to purchase Prostatype Genomics AB (publ) stock?
You can buy PGO.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prostatype Genomics AB (publ)?
The stock symbol or ticker of Prostatype Genomics AB (publ) is PGO.F.
Which industry does the Prostatype Genomics AB (publ) company belong to?
The Prostatype Genomics AB (publ) industry is Diagnostics & Research.
How many shares does Prostatype Genomics AB (publ) have in circulation?
The max supply of Prostatype Genomics AB (publ) shares is 831.54M.
What is Prostatype Genomics AB (publ) Price to Earnings Ratio (PE Ratio)?
Prostatype Genomics AB (publ) PE Ratio is now.
What was Prostatype Genomics AB (publ) earnings per share over the trailing 12 months (TTM)?
Prostatype Genomics AB (publ) EPS is 0 EUR over the trailing 12 months.
Which sector does the Prostatype Genomics AB (publ) company belong to?
The Prostatype Genomics AB (publ) sector is Healthcare.